HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2006-0669v1 2006-0669v2 25/7/1840    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coppi, E. Articles by Pedata, F. Search for Related Content PubMed PubMed Citation Articles by Coppi, E. Articles by Pedata, F.

TISSUE-SPECIFIC STEM CELLS

ATP Modulates Cell Proliferation and Elicits Two Different Electrophysiological Responses in Human Mesenchymal Stem Cells

^aDepartment of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy;
^bIstituto di Ricovero e Cura a Carattere Scientifico, Centro Neurolesi "Bonino-Pulejo," Messina, Italy;
^cDepartment of Haematology, Ospedale di Careggi, Florence, Italy

Key Words. Adenosine triphosphate • P2 receptors • P2 antagonists • Human mesenchymal stem cells • Patch clamp • Cell proliferation

Correspondence: Felicita Pedata, B.Sci., Department of Preclinical and Clinical Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. Telephone: +39 055 4271.262; Fax: +39 055 4271.280; e-mail: felicita.pedata{at}unifi.it

Received October 23, 2006; accepted for publication April 10, 2007.
First published online in STEM CELLS EXPRESS   April 19, 2007.



Bone marrow-derived human mesenchymal stem cells (hMSCs) have the potential to differentiate into several cell lines. Extracellular adenosine 5'-triphosphate (ATP) acts as a potent signaling molecule mediating cell-to-cell communication. Particular interest has been focused in recent years on the role of ATP in stem cell proliferation and differentiation. In the present work, we demonstrate that hMSCs at early stages of culture (P0–P5) spontaneously release ATP, which decreases cell proliferation. Increased hMSC proliferation is induced by the unselective P2 antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonate (PPADS) and by the selective P2Y₁ antagonist 2'-deoxy-N⁶-methyladenosine3',5'-bisphosphate (MRS 2179). A functional role of extracellular ATP in modulating ionic conductances with the whole-cell and/or perforated patch-clamp techniques was also investigated. Exogenous ATP increased both the voltage-sensitive outward and inward currents in 47% of cells, whereas, in 31% of cells, only an increase in inward currents was found. Cells responding in this dual manner to ATP presented different resting membrane potentials. Both ATP-induced effects had varying sensitivity to the P2 antagonists PPADS and MRS 2179. Outward ATP-sensitive currents are carried by potassium ions, since they are blocked by cesium replacement and are Ca²⁺-dependent because they are eliminated in the presence of 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. On the basis of different electrophysiological and pharmacological characteristics, we conclude that outward ATP-sensitive currents are due to Ca²⁺-dependent K⁺-channel activation following stimulation of P2Y receptors, whereas inward ATP-sensitive currents are mediated by P2X receptor activation. In summary, ATP released in early life stages of hMSCs modulates their proliferation rate and likely acts as one of the early factors determining their cell fate.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				G. Burnstock Unresolved issues and controversies in purinergic signalling J. Physiol., July 15, 2008; 586(14): 3307 - 3312. [Abstract] [Full Text] [PDF]